Private company

Calithera Biosciences, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address343 Oyster Point Blvd #200, South San Francisco, Ca 940802
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

-1183.9%Operating margin3
-1180.4%Net margin3
-1373.0%Return on equity3
-$66.4MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Other costs100¢$9.8M

Out of $9.8M in revenue.3 The company lost money this year.

Financial statements

Revenue453$9.8M in 2021−62% since 2017
0$10.0M$20.0M$30.0M2017: $26.0M$26.0M20172018: $22.3M$22.3M2018−14%2021: $9.8M$9.8M2021−56%
Operating income64573-$115.4M in 2021+201% since 2016
-$150.0M-$100.0M-$50.0M02016: -$38.3M-$38.3M20162017: -$29.7M-$29.7M2017−23%2018: -$57.3M-$57.3M2018+93%2019: -$92.9M-$92.9M2019+62%2020: -$91.4M-$91.4M2020−2%2021: -$115.4M-$115.4M2021+26%
Net income64573-$115.1M in 2021+203% since 2016
-$150.0M-$100.0M-$50.0M02016: -$38.0M-$38.0M20162017: -$27.8M-$27.8M2017−27%2018: -$54.6M-$54.6M2018+96%2019: -$89.9M-$89.9M2019+64%2020: -$90.1M-$90.1M2020+0%2021: -$115.1M-$115.1M2021+28%
Fiscal year201620172018201920202021
Revenue$26.0M4$22.3M5$9.8M3
Research and development$27.7M6$43.1M4$66.2M5$76.3M5$71.0M5
Operating income-$38.3M6-$29.7M4-$57.3M5-$92.9M7-$91.4M3-$115.4M3
Income tax$06$04$05$07$03$03
Net income-$38.0M6-$27.8M4-$54.6M5-$89.9M7-$90.1M3-$115.1M3
Earnings per share-$26.203-$31.163
Earnings per share (diluted)-$26.203-$31.163

Compare Calithera Biosciences, Inc. with another company

Recent filings

  1. May 26, 20234
  2. Mar 31, 202310-K
  3. Jan 31, 20234 FORM 4 SUBMISSION
  4. Jan 25, 20238-K
  5. Jan 25, 20234 FORM 4 SUBMISSION
  6. Jan 25, 20234 FORM 4 SUBMISSION
  7. Jan 25, 20234 FORM 4 SUBMISSION
  8. Jan 25, 20234 FORM 4 SUBMISSION
  9. Jan 25, 20234 FORM 4 SUBMISSION
  10. Jan 9, 20238-K
  11. Nov 14, 20228-K
  12. Nov 14, 202210-Q
  13. Sep 29, 20228-K
  14. Aug 16, 202210-Q
  15. Aug 15, 20228-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1